Pharmaceuticals, Biotechnology and Life Sciences
SBTI ID
40011645
Localisation
Canada
Northern America
Secteur d'activité
Pharmaceuticals, Biotechnology and Life Sciences
Type d'organisation
Corporate
Dernière mise à jour
18/12/2025
Statut
Classification
1.5°C
Année cible
2035
Near-Term Targets: CellCarta commits to reduce absolute scope 1 and 2 GHG emissions 63.0% by 2035 from a 2024 base year. CellCarta also commits to reduce absolute scope 3 GHG emissions from fuel- and energy-related activities 37.5% within the same timeframe. CellCarta further commits that 81.14% of its suppliers by emissions covering purchased goods and services, capital goods and upstream transportation and distribution, will have science-based targets by 2030.
The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C
Source : Science Based Targets initiative | Données publiques